Is ESALF or XYLD a better dividend investment in 2026?

ESALF currently yields 3.60% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: XYLD offers higher current income.

What is the dividend yield difference between ESALF and XYLD?

ESALF has a forward dividend yield of 3.60% ($1.08/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 7.38 percentage points.

Home › Compare › ESALF vs XYLD

ESALF vs XYLD: Dividend Comparison 2026

ESALF yields 3.60% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ESALF wins by $93.00 in total portfolio value

INVESTMENT

TIME HORIZON10 years

ESALF

● Live price

3.60%

Share price

$30.00

Annual div

$1.08

5Y div CAGR

0.4%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$474.23

Full ESALF calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — ESALF vs XYLD

📍 ESALF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ESALF	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ESALF + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ESALF pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESALF

Annual income on $10K today (after 15% tax)

$306.00/yr

After 10yr DRIP, annual income (after tax)

$403.10/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, XYLD beats the other by $2,333.07/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESALF + XYLD for your $10,000?

ESALF: 50%XYLD: 50%

100% XYLD50/50100% ESALF

Portfolio after 10yr

$25.3K

Annual income

$1,846.62/yr

Blended yield

7.29%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESALF buys

XYLD buys

No recent congressional trades found for ESALF or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricESALFXYLD

Forward yield	3.60%	10.98% ✓
Annual dividend / share	$1.08	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0.4% ✓	0%
Portfolio after 10y	$25.4K ✓	$25.3K
Annual income after 10y	$474.23	$3,219.02 ✓
Total dividends collected	$4.2K	$19.6K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: ESALF vs XYLD ($10,000, DRIP)

Year	ESALF Portfolio	ESALF Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$11,061	$361.44	$10,818	$1,098.39	+$243.00 → ESALF
2	$12,211	$375.14	$11,738	$1,222.51	+$473.00 → ESALF
3	$13,454	$388.58	$12,774	$1,364.64	+$680.00 → ESALF
4	$14,798	$401.74	$13,944	$1,527.86	+$854.00 → ESALF
5	$16,248	$414.60	$15,270	$1,715.87	+$978.00 → ESALF
6	$17,813	$427.16	$16,775	$1,933.09	+$1.0K → ESALF
7	$19,499	$439.41	$18,490	$2,184.87	+$1.0K → ESALF
8	$21,315	$451.34	$20,450	$2,477.63	+$865.00 → ESALF
9	$23,270	$462.94	$22,697	$2,819.19	+$573.00 → ESALF
10	$25,373	$474.23	$25,280	$3,219.02	+$93.00 → ESALF

ESALF vs XYLD: Complete Analysis 2026

ESALF — Stock

Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.

Full ESALF Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this ESALF vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESALF vs SCHD ESALF vs JEPI ESALF vs O ESALF vs KO ESALF vs MAIN ESALF vs QYLD ESALF vs JEPQ ESALF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.